Research
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study
BMJ 2023; 382 doi: https://doi.org/10.1136/bmj-2022-075286 (Published 25 July 2023) Cite this as: BMJ 2023;382:e075286Linked Opinion
Why older adults can continue to benefit from covid-19 boosters
Data supplement
Web extra
- Data Supplement - Web appendix: Supplementary appendix
Related articles
- Research Published: 06 July 2022; BMJ 378 doi:10.1136/bmj-2022-071502
- Research Published: 24 May 2022; BMJ 377 doi:10.1136/bmj-2022-071113
- Opinion Published: 25 July 2023; BMJ 382 doi:10.1136/bmj.p1662
- Letter Published: 21 September 2023; BMJ 382 doi:10.1136/bmj.p2100
See more
- Introductory AddressProv Med Surg J October 03, 1840, s1-1 (1) 1-4; DOI: https://doi.org/10.1136/bmj.s1-1.1.1
- Report of the Meeting of the Eastern Branch of the Provincial Association at Bury St. Edmond'sProv Med Surg J October 03, 1840, s1-1 (1) 10-13; DOI: https://doi.org/10.1136/bmj.s1-1.1.10
- Mr. Warburton's Bill for the Regulation of the Medical ProfessionProv Med Surg J October 03, 1840, s1-1 (1) 13-15; DOI: https://doi.org/10.1136/bmj.s1-1.1.13
- An Atlas of Plates, illustrative of the Principles and Practice of Obstetric Medicine and Surgery, with descriptive LetterpressProv Med Surg J October 03, 1840, s1-1 (1) 4; DOI: https://doi.org/10.1136/bmj.s1-1.1.4
- A Practical Treatise on the Diseases peculiar to Women, illustrated by Cases, &cProv Med Surg J October 03, 1840, s1-1 (1) 4-5; DOI: https://doi.org/10.1136/bmj.s1-1.1.4-a
Cited by...
- Methodological Challenges using Routine Clinical Care Data for Real-World Evidence: a Rapid Review utilizing a systematic literature search and focus group discussion
- Exploring the Application of Target Trial Emulation in Vaccine Evaluation: Scoping Review
- Comparative effectiveness of bivalent BA.4.5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: a nationwide cohort study
- Bivalent COVID-19 vaccines boost the capacity of pre-existing SARS-CoV-2-specific memory B cells to cross-recognize Omicron subvariants
- Distinct COVID-19 vaccine combinations result in divergent immune responses
- Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
- A Systematic Review and Meta-Analysis on the Effectiveness of Bivalent mRNA Booster Vaccines against Omicron Variants
- Durability of protection from original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the United States -- September 2022-August 2023
- Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
- Covid-19 boosters: improving patient information leaflets
- Why older adults can continue to benefit from covid-19 boosters